ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum

• Belzutifan: Primary Tx for Bilat Juxtapapillary Retinal Hemangioblastoma in VHL Patient

  On this episode of the JVRD Author's Forum podcast, Dr. Nikhil Batra of the Dartmouth School of Medicine discusses "Belzutifan as the Primary Treatment of Bilateral Juxtapapillary Retinal Hemangioblastoma in a Patient With von Hippel–Lindau Disease," published in the May/June 2025 issue of JVRD.  Host Dr. Timothy Murray and Dr. Batra discuss how belzutifan, a HIF-2α inhibitor, was used off-label to successfully treat bilateral optic nerve hemangioblastomas in a patient with Von Hippel-Lindau Disease, resulting in significant tumor regression and visual improvement. Hear how this targeted therapy may represent a promising new direction in managing complex retinal tumors that are difficult to treat with traditional approaches.

  --------  

  11:25

  --------

  11:25
• Biosimilar Ranibizumab (Ranieyes) Safety and Efficacy in the Real World: BRESER Study

  On this episode of the JVRD Author's Forum podcast, Dr. David Eichenbaum of Retina Vitreous Associates of Florida discusses "Biosimilar Ranibizumab (RaniEyes) Safety and Efficacy in the Real World: BRESER Study," published in the May/June 2025 issue of JVRD. Host Dr. Timothy Murray and Dr. Eichenbaum talk about how biosimilars are developed and approved, and why real-world data is essential for evaluating their safety and effectiveness on a large scale. Learn why cost, access, and post-market surveillance are important factors in the growing role of biosimilars in retina care.For more information, visit www.ASRS.org/JVRDForum.Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.

  --------  

  12:39

  --------

  12:39
• Diabetic Retinopathy Disease Burden in Patients With Lower Household Incomes vs Higher Household Incomes

  On this episode of the JVRD Author’s Forum podcast, Dr. Stefanie Schuman of the Duke Eye Center discusses 'Diabetic Retinopathy Disease Burden in Patients With Lower Household Incomes vs Higher Household Incomes,' published in the May/June 2025 issue of JVRD. Host Dr. Timothy Murray and Dr. Schuman discuss her study examining how household income, estimated by ZIP code, impacts the disease burden of diabetic retinopathy at presentation. Hear how socioeconomic barriers like access to care, diabetes control, and follow-up challenges contribute to worse outcomes, and why addressing social determinants of health is key to improving equity in retinal care.For more information, visit www.ASRS.org/JVRDForum.Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.

  --------  

  11:27

  --------

  11:27
• Postoperative Methotrexate to Reduce Reoperation Rate and Improve Vision in Patients With Complex Retinal Detachments, Advanced Diabetic Retinopathy, and Trauma

  In this episode of the JVRD Authors Forum, host Dr. Timothy Murray speaks with Dr. Alan Franklin of the Diagnostic and Medical Clinic in Mobile, Alabama, about his study exploring the use of postoperative methotrexate to reduce reoperation rates and improve outcomes in patients with complex retinal detachments, advanced diabetic retinopathy, and ocular trauma. Hear how real-world results sparked this investigation and why methotrexate may be a game-changer in managing proliferative vitreoretinopathy and retinal inflammation. For more information, visit www.ASRS.org/JVRDForum.Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.

  --------  

  2:56

  --------

  2:56
• Adult-Onset Presentations of Retinopathy Associated With Short Telomere Syndromes

  On this episode of the JVRD Author’s Forum podcast, Drs. Neil M. Bressler and Kristen E. Schratz discuss 'Adult-Onset Presentations of Retinopathy Associated With Short Telomere Syndromes,' published in the May/June 2025 issue of JVRD.In this compelling episode, Host Dr. Timothy Murray and Drs. Bressler and Schratz of the Johns Hopkins School of Medicine explore adult-onset retinal findings linked to short telomere syndromes—conditions more commonly associated with pediatric presentations. Learn how unexplained retinal vasculopathy in two adult patients led to a deeper understanding of systemic, life-threatening disorders, and why cross-specialty collaboration is key to early diagnosis. This episode underscores the critical role of retina specialists in identifying subtle ocular signs of complex genetic diseases. For more information, visit www.ASRS.org/JVRDForum.Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.

  --------  

  11:39

  --------

  11:39

Mais podcasts de Saúde e fitness

Podcasts em tendência em Saúde e fitness

Sobre ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum